Combination strategies are rapidly redefining treatment for HER2-positive solid tumors. | HER2 combination strategies are evolving. Hear how biology and next-generation antibodies are redefining treatment.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Early-onset cancers are rising among adults 18–49, reshaping how patients are diagnosed, supported, and engaged. This report…
By Moitreyee Chatterjee-Kishore, Ph.D., MBA, Head of Oncology Development, Astellas Pharma Inc. | How targeted protein degraders…
There’s a thing that happens in American healthcare.You've got these massive systems—pharma conglomerates, hospital networks,…
Pharma companies need to strengthen and modernize patient support programs to reflect rising rates of cancer in adults aged 18 to…
Artificial intelligence is transforming pharma, but success depends on more than powerful algorithms. Download this whitepaper to…
As China-developed assets gain more attention from biopharma dealmakers, some industry watchers want to cur | As China-developed…
